{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T12:17:09Z","timestamp":1783426629030,"version":"3.54.6"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.msard.2026.107332","type":"journal-article","created":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T14:39:50Z","timestamp":1782052790000},"page":"107332","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Predictors of early response to cladribine in mexican patients with multiple sclerosis: A real world multicenter retrospective cohort study"],"prefix":"10.1016","volume":"112","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-2309-4229","authenticated-orcid":false,"given":"CJ","family":"Moreno-Bernardino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I","family":"Trevi\u00f1o-Frenk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JF","family":"Ortiz-Maldonado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"NA","family":"S\u00e1nchez-Rosales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Skromne-Eisenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Cort\u00e9s-Enriquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Sauri-Suarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Del Le\u00f3n-Murillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AL","family":"Bazan-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Torres-Mora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0206-322X","authenticated-orcid":false,"given":"E","family":"G\u00f3mez- Figueroa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.msard.2026.107332_bib0001","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2023.578164","article-title":"Cladribine tablets in people with relapsing multiple sclerosis: a real-world multicentric study from southeast European MS centers","volume":"382","author":"Adamec","year":"2023","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.msard.2026.107332_bib0002","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2023.104735","article-title":"Safety and effectiveness of cladribine tablets for multiple sclerosis: results from a single-center real-world cohort","volume":"75","author":"Aerts","year":"2023","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2026.107332_bib0003","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.2174\/1570159X21666230322140711","article-title":"Real-world effectiveness of Cladribine for patients with multiple sclerosis: a Sicilian multicentric experience (Rewind Study)","volume":"22","author":"Arena","year":"2024","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.msard.2026.107332_bib0004","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000214527","article-title":"Association of brain age with physical disability and cognitive impairment in people with multiple sclerosis of the same age","volume":"106","author":"Bos","year":"2026","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2026.107332_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2023.104951","article-title":"Real-world use of cladribine tablets (completion rates and treatment persistence) in patients with multiple sclerosis in England: the CLARENCE study","volume":"79","author":"Brownlee","year":"2023","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2026.107332_bib0006","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ncl.2023.07.002","article-title":"Pathophysiology, diagnosis, treatment and emerging neurotherapeutic targets for progressive multiple sclerosis: the age of PIRA","volume":"42","author":"Carlson","year":"2024","journal-title":"Neurol. Clin."},{"key":"10.1016\/j.msard.2026.107332_bib0008","doi-asserted-by":"crossref","DOI":"10.1177\/1756285617753365","article-title":"Long-term effects of cladribine tablets on MRI activity outcomes in patients with relapsing-remitting multiple sclerosis: the CLARITY Extension study","volume":"11","author":"Comi","year":"2018","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"10.1016\/j.msard.2026.107332_bib0009","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1007\/s00415-012-6775-0","article-title":"MRI outcomes with cladribine tablets for multiple sclerosis in the CLARITY study","volume":"260","author":"Comi","year":"2013","journal-title":"J. Neurol."},{"key":"10.1016\/j.msard.2026.107332_bib0010","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.msard.2018.11.021","article-title":"Safety of cladribine tablets in the treatment of patients with multiple sclerosis: an integrated analysis","volume":"29","author":"Cook","year":"2019","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2026.107332_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2022.103838","article-title":"Clinical and MRI predictors of cognitive decline in patients with relapsing-remitting multiple sclerosis: a 2-year longitudinal study","volume":"65","author":"Dong","year":"2022","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2026.107332_bib0012","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1177\/13524585231161494","article-title":"Long-term follow-up of patients with relapsing multiple sclerosis from the CLARITY\/CLARITY Extension cohort of CLASSIC-MS: an ambispective study","volume":"29","author":"Giovannoni","year":"2023","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2026.107332_bib0013","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1177\/1352458517703193","article-title":"No evident disease activity\u201d: the use of combined assessments in the management of patients with multiple sclerosis","volume":"23","author":"Giovannoni","year":"2017","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2026.107332_bib0014","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000213343","article-title":"The burden of multiple sclerosis in Mexico","volume":"104","author":"G\u00f3mez-Figueroa","year":"2025","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2026.107332_bib0015","doi-asserted-by":"crossref","DOI":"10.1177\/17562864251399595","article-title":"Real-world effectiveness of horizontal switching between disease-modifying therapies in multiple sclerosis: a retrospective analysis of the MSBase Registry","volume":"18","author":"Gomez-Figueroa","year":"2025","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"10.1016\/j.msard.2026.107332_bib0016","article-title":"Cognitive reserve and its contribution to predicting cognitive performance in multiple sclerosis","volume":"107","author":"Moini","year":"2026","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2026.107332_bib0018","article-title":"Early clinical effect of cladribine in patients with highly active multiple sclerosis in Mexico","volume":"10","author":"Sauri-Suarez","year":"2024","journal-title":"Mult. Scler. J. Exp. Transl. Clin."},{"key":"10.1016\/j.msard.2026.107332_bib0019","doi-asserted-by":"crossref","first-page":"5841","DOI":"10.1007\/s10072-024-07763-7","article-title":"Cladribine use trend in Latin America: the changes in patient profile impact in the drug effectiveness","volume":"45","author":"Silva","year":"2024","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.msard.2026.107332_bib0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2022.104491","article-title":"Real-world experience of cladribine treatment in relapsing-remitting multiple sclerosis: a Danish nationwide study","volume":"70","author":"Sorensen","year":"2023","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2026.107332_bib0022","doi-asserted-by":"crossref","DOI":"10.1007\/s00415-026-13815-z","article-title":"Iron accumulation in multiple sclerosis and implications for cognitive and clinical progression: a systematic review of advanced neuroimaging studies","volume":"273","author":"Susinna","year":"2026","journal-title":"J. Neurol."},{"key":"10.1016\/j.msard.2026.107332_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2026.107080","article-title":"Cognition beyond relapses: cognitive progression independent of relapse activity reflects early smoldering neurodegeneration in multiple sclerosis","volume":"108","author":"Ziccardi","year":"2026","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2026.107332_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2026.107080","article-title":"Cognition beyond relapses: cognitive progression independent of relapse activity reflects early smoldering neurodegeneration in multiple sclerosis","volume":"108","author":"Ziccardi","year":"2026","journal-title":"Mult. Scler. Relat. Disord."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034826003688?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034826003688?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T11:37:16Z","timestamp":1783424236000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034826003688"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":21,"alternative-id":["S2211034826003688"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2026.107332","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predictors of early response to cladribine in mexican patients with multiple sclerosis: A real world multicenter retrospective cohort study","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2026.107332","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107332"}}